Form 4: Celldex Therapeutics Executive Exercises Options and Sells Shares

Elizabeth Crowley, SR. VP & CPDO of Celldex Therapeutics, exercised stock options and sold shares on June 14, 2024.

Summary

• On June 14, 2024, Elizabeth Crowley, SR. VP & CPDO of Celldex Therapeutics, exercised incentive stock options to purchase 30,000 shares of common stock at a price of $10.38 per share.
• Simultaneously, Crowley sold 30,000 shares of common stock at a weighted average price of $34.8654 per share, with individual sales ranging from $34.51 to $35.39.
• Following these transactions, Crowley directly owns 9,074 shares of Celldex Therapeutics common stock and holds options for 46,500 shares.
• The incentive stock option exercised was fully vested as of June 18, 2024, and was originally granted with an expiration date of June 18, 2030.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider trading activity. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which is important for investors to monitor.

Stakeholder Impact

• The transaction may have a minor impact on shareholders as it reflects an executive's decision to exercise options and sell shares, which could be interpreted in various ways.

Key Dates